Operating Partner
and access,
Christophe Lavigne is an Operating Partner at Keensight. A Franco-American entrepreneur, Christophe Lavigne founded LDR Medical, a world leader in next-generation spinal implant devices, in 2000. Supported by Keensight since 2002, Christophe successfully managed the exceptional growth of his company right up to its IPO on the Nasdaq in October 2013, and through to its acquisition in 2016 by US group Zimmer-Biomet for US$1.1 billion. At that time, LDR had over 600 employees, more than 350 distributors and agents across the United States, revenues of approximately US$185m, and operations in more than 35 countries. Based in Austin, Texas, Christophe is also a musician, songwriter, and producer.